Renaissance Technologies - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 922 filers reported holding NOVARTIS A G in Q2 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$268,589
+13.0%
2,636,845
+12.0%
0.46%
+33.9%
Q2 2023$237,627
-15.2%
2,354,845
-22.7%
0.34%
-8.1%
Q1 2023$280,365
-9.7%
3,047,444
-10.9%
0.37%
-12.5%
Q4 2022$310,350
-99.9%
3,420,970
+7.5%
0.42%
+24.3%
Q3 2022$241,854,000
-24.4%
3,181,870
-15.9%
0.34%
-9.8%
Q2 2022$319,808,000
+7.8%
3,783,370
+11.9%
0.38%
+8.9%
Q1 2022$296,698,000
-9.0%
3,381,170
-9.3%
0.35%
-14.3%
Q4 2021$326,051,000
+20.6%
3,727,570
+12.7%
0.41%
+16.3%
Q3 2021$270,466,000
+23.0%
3,307,237
+37.2%
0.35%
+27.4%
Q2 2021$219,883,000
+8.5%
2,409,939
+1.7%
0.27%
+8.7%
Q1 2021$202,617,000
-54.9%
2,370,339
-50.2%
0.25%
-48.4%
Q4 2020$449,329,000
-22.7%
4,758,333
-28.8%
0.49%
-15.9%
Q3 2020$581,050,000
-19.8%
6,681,808
-19.4%
0.58%
-7.2%
Q2 2020$724,451,000
+3.5%
8,294,608
-2.3%
0.62%
-8.1%
Q1 2020$700,117,000
+12.0%
8,491,408
+28.6%
0.68%
+41.7%
Q4 2019$625,066,000
+38.2%
6,601,182
+26.8%
0.48%
+25.3%
Q3 2019$452,328,000
+21.7%
5,205,155
+27.9%
0.38%
+17.1%
Q2 2019$371,573,000
+20.2%
4,069,357
+26.6%
0.33%
+16.4%
Q1 2019$309,042,000
+3.0%
3,214,500
-8.1%
0.28%
-14.3%
Q4 2018$300,034,000
+17.4%
3,496,498
+17.8%
0.33%
+24.7%
Q3 2018$255,671,000
-43.9%
2,967,398
-49.6%
0.26%
+5.6%
Q2 2018$455,971,000
+176.9%
5,892,986
+189.3%
0.25%
+38.3%
Q1 2018$164,667,000
+14.3%
2,036,698
+18.7%
0.18%
+13.2%
Q4 2017$144,084,000
+16.2%
1,716,100
+18.8%
0.16%
+8.9%
Q3 2017$123,985,000
+0.7%
1,444,200
-2.1%
0.15%
-7.0%
Q2 2017$123,077,000
-32.6%
1,474,500
-40.0%
0.16%
-38.4%
Q1 2017$182,593,000
+9.6%
2,458,498
+7.5%
0.26%
-3.4%
Q4 2016$166,585,000
-16.1%
2,287,000
-9.1%
0.26%
-24.8%
Q3 2016$198,592,000
+6.5%
2,515,098
+11.3%
0.35%
-1.1%
Q2 2016$186,522,000
-21.1%
2,260,598
-30.8%
0.36%
-21.1%
Q1 2016$236,480,000
-11.1%
3,264,498
+5.6%
0.45%
-22.4%
Q4 2015$265,967,000
+72.0%
3,091,198
+83.7%
0.58%
+57.2%
Q3 2015$154,646,000
+32.5%
1,682,398
+41.8%
0.37%
+38.7%
Q2 2015$116,690,000
-3.6%
1,186,598
-3.4%
0.27%
+3.1%
Q1 2015$121,083,000
+51.8%
1,227,898
+42.6%
0.26%
+33.7%
Q4 2014$79,762,000
+196.4%
860,800
+201.1%
0.19%
+160.8%
Q3 2014$26,912,000
+2024.1%
285,900
+1942.1%
0.07%
+2366.7%
Q2 2014$1,267,000
-84.5%
14,000
-85.4%
0.00%
-85.0%
Q1 2014$8,162,000
-84.6%
96,000
-85.4%
0.02%
-84.3%
Q4 2013$52,994,000
+62.9%
659,298
+55.4%
0.13%
+60.8%
Q3 2013$32,540,000424,2000.08%
Other shareholders
NOVARTIS A G shareholders Q2 2017
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders